These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28315344)

  • 1. Further analysis of the inhibition by agmatine on the cardiac sympathetic outflow: Role of the α
    Cobos-Puc L; Aguayo-Morales H; Ventura-Sobrevilla J; Luque-Contreras D; Chin-Chan M
    Eur J Pharmacol; 2017 Jun; 805():75-83. PubMed ID: 28315344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α2A-adrenoceptors, but not nitric oxide, mediate the peripheral cardiac sympatho-inhibition of moxonidine.
    Cobos-Puc LE; Aguayo-Morales H; Silva-Belmares Y; González-Zavala MA; Centurión D
    Eur J Pharmacol; 2016 Jul; 782():35-43. PubMed ID: 27112661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological analysis of the cardiac sympatho-inhibitory actions of moxonidine and agmatine in pithed spontaneously hypertensive rats.
    Cobos-Puc LE; Sánchez-López A; Centurión D
    Eur J Pharmacol; 2016 Nov; 791():25-36. PubMed ID: 27565220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological analysis of the inhibition produced by moxonidine and agmatine on the vasodepressor sensory CGRPergic outflow in pithed rats.
    Rubio-Beltrán E; Labastida-Ramírez A; Hernández-Abreu O; MaassenVanDenBrink A; Villalón CM
    Eur J Pharmacol; 2017 Oct; 812():97-103. PubMed ID: 28694067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The α2-adrenoceptors mediating inhibition of the vasopressor sympathetic outflow in pithed rats: pharmacological correlation with α2A, α2B and α2C subtypes.
    Villamil-Hernández MT; Alcántara-Vázquez O; Sánchez-López A; Centurión D
    Eur J Pharmacol; 2013 Oct; 718(1-3):245-52. PubMed ID: 24028939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of the inhibition by moxonidine and agmatine on the cardioaccelerator sympathetic outflow in pithed rats.
    Cobos-Puc LE; Villalón CM; Ramírez-Rosas MB; Sánchez-López A; Lozano-Cuenca J; Gómez-Díaz B; MaassenVanDenBrink A; Centurión D
    Eur J Pharmacol; 2009 Aug; 616(1-3):175-82. PubMed ID: 19527708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centhaquin antinociception in mice is mediated by α2A- and α2B- but not α2C-adrenoceptors.
    Bhalla S; Ali I; Andurkar SV; Gulati A
    Eur J Pharmacol; 2013 Sep; 715(1-3):328-36. PubMed ID: 23712005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific role of α2A - and α2B -, but not α2C -, adrenoceptor subtypes in the inhibition of the vasopressor sympathetic out-flow in diabetic pithed rats.
    Altamirano-Espinoza AH; Manrique-Maldonado G; Marichal-Cancino BA; Villalón CM
    Basic Clin Pharmacol Toxicol; 2015 Jul; 117(1):31-8. PubMed ID: 25407049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological evidence that alpha2A- and alpha2C-adrenoceptors mediate the inhibition of cardioaccelerator sympathetic outflow in pithed rats.
    Cobos-Puc LE; Villalón CM; Sánchez-López A; Lozano-Cuenca J; Pertz HH; Görnemann T; Centurión D
    Eur J Pharmacol; 2007 Jan; 554(2-3):205-11. PubMed ID: 17109851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further evidence for the role of histamine H3, but not H1, H2 or H4, receptors in immepip-induced inhibition of the rat cardioaccelerator sympathetic outflow.
    Pinacho-García M; Marichal-Cancino BA; Villalón CM
    Eur J Pharmacol; 2016 Feb; 773():85-92. PubMed ID: 26826593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological profile of the inhibition by dihydroergotamine and methysergide on the cardioaccelerator sympathetic outflow in pithed rats.
    Lozano-Cuenca J; Muñoz-Islas E; González-Hernández A; Centurión D; Cobos-Puc LE; Sánchez-López A; Pertz HH; Villalón CM
    Eur J Pharmacol; 2009 Jun; 612(1-3):80-6. PubMed ID: 19356724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective role of α
    Rivera-Mancilla E; Villanueva-Castillo B; Altamirano-Espinoza AH; Manrique-Maldonado G; Villalón CM
    Eur J Pharmacol; 2022 Aug; 929():175138. PubMed ID: 35798051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological identification of α1- and α2-adrenoceptor subtypes involved in the vasopressor responses induced by ergotamine in pithed rats.
    Villamil-Hernández MT; Alcántara-Vázquez O; Sánchez-López A; Centurión D
    Eur J Pharmacol; 2013 Sep; 715(1-3):262-9. PubMed ID: 23707349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that some imidazoline derivatives inhibit peripherally the vasopressor sympathetic outflow in pithed rats.
    Monroy-Ordoñez EB; Villalón CM; Cobos-Puc LE; Márquez-Conde JA; Sánchez-López A; Centurión D
    Auton Neurosci; 2008 Dec; 143(1-2):40-5. PubMed ID: 18774761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological evidence that metformin blocks the vasopressor responses mediated by stimulation of α
    de la Cruz SH; Medina-Terol GJ; Beltrán-Ornelas JH; Gomez CB; Morato-Valderrama Y; Sánchez-López A; Centurión D
    Eur J Pharmacol; 2018 Feb; 820():130-137. PubMed ID: 29248426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization and CNS effects of a novel highly selective alpha2C-adrenoceptor antagonist JP-1302.
    Sallinen J; Höglund I; Engström M; Lehtimäki J; Virtanen R; Sirviö J; Wurster S; Savola JM; Haapalinna A
    Br J Pharmacol; 2007 Feb; 150(4):391-402. PubMed ID: 17220913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different roles of alpha2-adrenoceptor subtypes in non-pregnant and late-pregnant uterine contractility in vitro in the rat.
    Gáspár R; Gál A; Gálik M; Ducza E; Minorics R; Kolarovszki-Sipiczki Z; Klukovits A; Falkay G
    Neurochem Int; 2007 Oct; 51(5):311-8. PubMed ID: 17664026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renoprotective effect of yohimbine on ischaemia/reperfusion-induced acute kidney injury through α2C-adrenoceptors in rats.
    Shimokawa T; Tsutsui H; Miura T; Nishinaka T; Terada T; Takama M; Yoshida S; Tanba T; Tojo A; Yamagata M; Yukimura T
    Eur J Pharmacol; 2016 Jun; 781():36-44. PubMed ID: 27041645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological identification of the α₂-adrenoceptor subtypes mediating the vasopressor responses to B-HT 933 in pithed rats.
    Villamil-Hernández MT; Alcántara-Vázquez O; Sánchez-López A; Manrique-Maldonado G; Villalón CM; Centurión D
    Eur J Pharmacol; 2012 Sep; 691(1-3):118-24. PubMed ID: 22713550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical characterization of BRL 44408: antidepressant- and analgesic-like activity through selective alpha2A-adrenoceptor antagonism.
    Dwyer JM; Platt BJ; Rizzo SJ; Pulicicchio CM; Wantuch C; Zhang MY; Cummons T; Leventhal L; Bender CN; Zhang J; Kowal D; Lu S; Rajarao SJ; Smith DL; Shilling AD; Wang J; Butera J; Resnick L; Rosenzweig-Lipson S; Schechter LE; Beyer CE
    Int J Neuropsychopharmacol; 2010 Oct; 13(9):1193-205. PubMed ID: 20047711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.